Video

Dr. Shaughnessy on Challenges With CAR T-Cell Therapy in Hematologic Malignancies

Paul J. Shaughnessy, MD, discusses challenges with CAR T-cell therapy in relapsed/refractory hematologic malignancies.

Paul J. Shaughnessy, MD, hematologist, oncologist, and medical director of Adult Blood and Marrow Transplant Program, at the Methodist Hospital, discusses challenges with CAR T-cell therapy in relapsed/refractory hematologic malignancies.

Often, patients who require CAR T-cell therapy have experienced multiple relapses, are refractory to available treatments, and have rapidly growing disease, says Shaughnessy. Moreover, in some cases, patients are unable to wait for their lymphocytes to be collected, engineered, and grown into CAR T cells.

Improving time-to-treatment with CAR T-cell therapy is an area of significant development, adds Shaughnessy. For example, allogeneic CAR T cells are a potential off-the-shelf option that would allow the product to be offered more readily.

Another challenge is preventing patients from relapsing following CAR T-cell therapy, Shaughnessy says. Some potential strategies to increase the durability of the therapy include dual-targeting antigens and augmenting CAR T with immunotherapy or radiation.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Video

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Apr 8th 2025 - May 14th 2025

online-activity